BA
DGX icon

Bridgewater Advisors’s Quest Diagnostics DGX Stock Holding History

Bridgewater Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,645
Closed -$2.19M – 242
2021
Q4 		$2.19M Buy
12,645
+826
+7% +$126K 0.48% 44
2021
Q3 		$1.72M Sell
11,819
-275
-2% -$40.2K 0.47% 47
2021
Q2 		$1.6M Buy
12,094
+170
+1% +$22.3K 0.51% 49
2021
Q1 		$1.62M Buy
+11,924
New +$1.47M 0.82% 34

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Bridgewater Advisors's DGX Position: Q1 2022 in Review

Bridgewater Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 12,645 shares — an estimated $2.19M sold.

Bridgewater Advisors first reported a position in DGX in Q1 2021 and held it in 4 quarters. The position peaked at $2.19M in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Bridgewater Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Bridgewater Advisors sold 12,645 Quest Diagnostics shares in Q1 2022, an estimated $2.19M.
  • Bridgewater Advisors first reported a position in Quest Diagnostics in Q1 2021 and held it in 4 quarters.
  • Bridgewater Advisors's Quest Diagnostics position peaked at $2.19M in Q4 2021.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Bridgewater Advisors's 13F filing for Q1 2022, filed 5 May 2022.